Race and prostate weight as independent predictors for biochemical recurrence after radical prostatectomy

Prostate Cancer and Prostatic Diseases

Volumn 11, Issue 4, 2008, Pages 371-376

  Schroeck, F R ^a   Sun, L ^a   Freedland, S J ^a   Jayachandran, J ^a   Robertson, C N ^a   Moul, J W ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AFRICAN AMERICAN; AGE DISTRIBUTION; ARTICLE; BIOCHEMISTRY; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER RECURRENCE; COHORT ANALYSIS; DIAGNOSTIC ACCURACY; GLEASON SCORE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NOMOGRAM; ORGAN WEIGHT; POSTOPERATIVE PERIOD; PREDICTION; PRIORITY JOURNAL; PROSTATE WEIGHT; PROSTATECTOMY; RACE DIFFERENCE; RECURRENCE RISK; SEMINAL VESICLE;

AGED; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; ORGAN SIZE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; SURVIVAL RATE; TIME FACTORS;

EID: 56249110485     PISSN: 13657852     EISSN: 14765608     Source Type: Journal    
DOI: 10.1038/pcan.2008.18     Document Type: Article

References (32)

1. Freedland SJ, Moul JW. Prostate specific antigen recurrence after definitive therapy. J Urol 2007; 177: 1985-1991.
2. Stephenson AJ, Scardino PT, Eastham JA, Bianco Jr FJ, Dotan ZA, Fearn PA et al. Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Natl Cancer Inst 2006; 98: 715-717.
3. Stephenson AJ, Scardino PT, Eastham JA, Bianco Jr FJ, Dotan ZA, DiBlaslo CJ et al. Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Clin Oncol 2005; 23: 7005-7012.
4. Kattan MW, Wheeler TM, Scardino PT. Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer. J Clin Oncol 1999; 17: 1499-1507.
5. Mouraviev V, Mayes JM, Sun L, Madden JF, Moul JW, Polascik TJ. Prostate cancer laterality as a rationale of focal ablative therapy for the treatment of clinically localized prostate cancer. Cancer 2007; 110: 906-910.
6. R Development Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria 2007. http://www.R-project.org.
7. Harrell FE. Design: Design Package. R package version 2.1-1 2007.
8. Harrell FE. Hmisc: Harrell Miscellaneous. R package version 3.4-2 2007.
9. Hamilton RJ, Aronson WJ, Presti Jr JC, Terris MK, Kane CJ, Amling CL et al. Race, biochemical disease recurrence, and prostate-specific antigen doubling time after radical prostatectomy: Results from the SEARCH database. Cancer 2007; 110: 2202-2209.
10. Iselin CE, Box JW, Vollmer RT, Layfield LJ, Robertson JE, Paulson DF. Surgical control of clinically localized prostate carcinoma is eqiuvalent in African-American and white males. Cancer 1998; 83 2353-2360.
11. Eastham JA, Kattan MW. Disease recurrence in black and white men undergoing radical prostatectomy for clinical stage T1-T2 prostate cancer. J Urol 2000; 163: 143-145.
12. Cross CK, Shultz D, Malkowicz SB, Huang WC, Whittington R, Tomaszewski JE et al. Impact of race on prostate-specific antigen outcome after radical prostatectomy for clinically localized adenocarcinoma of the prostate. J Clin Oncol 2002; 20: 2863-2868.
13. Sohayda-CJ, Kupelian PA, Altsman KA, Klein EA. Race as an independent predictor of outcome after treatment for localized prostate cancer. J Urol 1999; 162: 1331-1336.
14. Nielsen ME, Han M, Mangold L, Humphreys E, Walsh PC, Partin AW et al Black race does not independently predict adverse outcome following radical retropubic prostatectomy at a tertiary referral center. J Urol 2006; 176: 515-519.
15. Powell IJ, Dey J, Dudley A, Pontes JE, Cher ML, Sakr W et al. Disease-free survival difference between African Americans and whites after radical prostatectomy for local prostate cancer: A multivariable analysis. Urology 2002; 59: 907-912.
16. Grossfeld GD, Latini DM, Downs T, Lubeck DP, Mehta SS, Carroll PR. Is ethnicity an independent predictor of prostate cancer recurrence after radical prostatectomy? J Urol 2002; 168: 2510-2515.
17. Tarman GJ, Kane CJ, Moul JW, Thrasher JB, Foley JP, Wilhite D et al Impact of socioeconomic status and race on clinical parameters of patients undergoing radical prostatectomy in an equal access health care system. Urology 2000; 56: 1016-1020.
18. Moul JW, Douglas TH, McCarthy WF, McLeod DG. Black race is an adverse prognostic factor for prostate cancer recurrence following radical prostatectomy in an equal access health care setting. J Urol 1996; 155: 1667-1673.
19. Powell IJ, Banerjee M, Bianco FJ, Wood Jr DP, Dey J, Lai Z et al. The effect of race/ethnicity on prostate cancer treatment outcome is conditional: A review of Wayne State University data. J Urol 2004; 171: 1508-1512.
20. Amling CL, Riffenburgh RH, Sun L, Moul JW, Lance RS, Kusuda L et al Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy. J Clin Oncol 2004; 22: 439-445.
21. Zorn KC, Orvieto MA, Mikhail AA, Gofrit ON, Lin S, Schaeffer AJ et al Effect of prostate weight on operative and postoperative outcomes of robotic-assisted laparoscopic prostatectomy. Urology 2007; 69 300-305.
22. Freedland SJ, Isaacs WB, Platz EA, Terris MK, Aronson WJ, Amling CL et al. Prostate size and risk of high-grade, advanced prostate cancer and biochemical progression after radical prostatectomy: A search database study. J Clin Oncol 2005; 23: 7546-7554.
23. Stamey TA, Yemoto CM, McNeal JE, Sigal BM, Johnstone IM. Prostate cancer is highly predictable: A prognostic equation based on all morphological variables in radical prostatectomy specimens. J Urol 2000; 163 1155-1160.
24. Foley CL, Bott SR, Thomas K, Parkinson MC, Kirby RS. A large prostate at radical retropubic prostatectomy does not adversely affect cancer control, continence or potency rates. BJU Int 2003; 92: 370-374.
25. 3 predicts for a favorable outcome after radical prostatectomy for localized prostate cancer. Urology 1998; 52: 631-636.
26. Msezane LP, Gofrit ON, Lin S, Shalhav AL, Zagaja GF, Zorn KC. Prostate weight: An independent predictor for positive surgical margins during robotic-assisted laparoscopic radical prostatectomy. Can J Urol 2007; 14: 3697-3701.
27. Nixon RG, Meyer GE, Brawer MK. Differences in prostate size between patients from University and Veterans Affairs Medical Center populations. Prostate 1999; 38: 144-150.
28. Terris MK, Prestigiacomo AF, Stamey TA. Comparison of prostate size in university and veterans affairs health care system patients with negative prostate biopsies. Urology 1998; 51: 412-414.
29. Vickers AJ, Bianco FJ, Serio AM, Eastham JA, Schrag D, Klein EA et al The surgical learning curve for prostate cancer control after radical prostatectomy. J Natl Cancer Inst 2007; 99: 1171-1177.
30. Bolla M, van Poppel H, Collette L, van Cangh P, Vekemans K, Da Pozzo L et al. Postoperative radiotherapy after radical prostatectomy: A randomised controlled trial (EORTC trial 22911). Lancet 2005; 366: 572-578.
31. Thompson Jr IM, Tangen CM, Paradelo J, Lucia MS, Miller G, Troyer D et al. Adjuvant radiotherapy for pathologically advanced prostate cancer: A randomized clinical trial. JAMA 2006; 296: 2329-2335.
32. Van der Kwast TH, Bolla M, Van Poppel H, Van Cangh P, Vekemans K, Da Pozzo L et al. Identification of patients with prostate cancer who benefit from immediate postoperative radiotherapy: EORTC 22911. J Clin Oncol 2007; 25: 4178-4186.